• ABBV
• AMGN
• BIIB
• BMY
• GILD
• JNJ
• LLY
• MRK
• MRNA
• PFE
• REGN

BofA reinstates pharma coverage

Bank of America reviews 11 U.S. pharma stocks, highlighting growth potential and challenges amid patent cliffs and pricing pressures while recommending buy, neutral, and underperform ratings.

• AAPL
• AMZN
• AXON
• CL
• DX
• EUR/USD
• GC
• HON
• INTC
• IXIC
• JNJ
• LCO
• MCHP
• MRK
• ON
• PG
• PLTR
• T
• USD/JPY
• VIX

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.17%

U.S. stocks were mixed with notable gains in tech and telecom sectors, while declines were seen in consumer goods and financials. Key stocks reached all-time highs.

• JNJ

J&J baby powder lawsuits stay paused amid bankruptcy trial plans

• JNJ
• LLY
• SNY

Sanofi plans to change hospital drug-discount program

• JNJ
• MIWO00000PUS
• NVO
• SWAV
• UK100

Healthcare executives expect more IPOs and corporate dealmaking in 2025

Healthcare executives see increased IPOs and M&A activity in 2025, citing geopolitical risks as major concerns, with confidence improving in the sector's outlook.

• JNJ
• LLY

Lilly sues US agency over blocking of drug-rebate program

Eli Lilly has sued HRSA for blocking its proposed drug discount changes under the federal 340B program, which aids low-income healthcare providers.

• AMZN
• CL
• DJI
• DX
• ENPH
• EUR/USD
• GC
• IXIC
• JNJ
• LCO
• MCD
• MMM
• NTRS
• ODFL
• PKG
• STX
• TDY
• US500
• USD/JPY
• VIX
• VZ
• WMT

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.96%

U.S. stocks closed lower, led by losses in Technology and Consumer sectors. Notable gainers included Northern Trust and Teledyne, while losses were seen in Enphase and McDonald's.

• JNJ

Starboard says Kenvue's skin health segment weighing on performance

Starboard Value finds Kenvue a bargain due to poor performance in skin health brands, urging focus on revenue and marketing improvements amid a stagnant sales environment.

• ADSK
• CRM
• JNJ
• MTCH
• PFE

Starboard Value takes stake in JNJ spin-off Kenvue- WSJ

Starboard Value has acquired a stake in Kenvue Inc, advocating for changes to improve stock performance, while also investing in other major companies like Pfizer.

• JNJ

J&J discontinues dengue drug study after changes in R&D portfolio

Johnson & Johnson discontinues a dengue prevention pill study, citing prioritization changes, though safety concerns were absent; efficacy results pending completion of final analyses.